Chimerix Performance
| CMRXDelisted Stock | USD 8.54 0.01 0.12% |
The firm shows a Beta (market volatility) of 1.35, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Chimerix will likely underperform. Chimerix right now shows a risk of 0.0%. Please confirm Chimerix sortino ratio, as well as the relationship between the semi variance and rate of daily change , to decide if Chimerix will be following its price patterns.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Chimerix has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Chimerix is not utilizing all of its potentials. The recent stock price disturbance, may contribute to short-term losses for the investors. ...more
| Begin Period Cash Flow | 27.7 M | |
| Free Cash Flow | -75.3 M |
Chimerix |
Chimerix Relative Risk vs. Return Landscape
If you would invest 854.00 in Chimerix on October 23, 2025 and sell it today you would earn a total of 0.00 from holding Chimerix or generate 0.0% return on investment over 90 days. Chimerix is currently does not generate positive expected returns and assumes 0.0% risk (volatility on return distribution) over the 90 days horizon. In different words, 0% of stocks are less volatile than Chimerix, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Chimerix Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Chimerix's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Chimerix, and traders can use it to determine the average amount a Chimerix's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0
| High Returns | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| CMRX |
Based on monthly moving average Chimerix is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Chimerix by adding Chimerix to a well-diversified portfolio.
Chimerix Fundamentals Growth
Chimerix Stock prices reflect investors' perceptions of the future prospects and financial health of Chimerix, and Chimerix fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Chimerix Stock performance.
| Return On Equity | -0.56 | |||
| Return On Asset | -0.34 | |||
| Operating Margin | (430.74) % | |||
| Current Valuation | 669.9 M | |||
| Shares Outstanding | 93.8 M | |||
| Price To Earning | (3.43) X | |||
| Price To Book | 6.58 X | |||
| Price To Sales | 3,779 X | |||
| Revenue | 212 K | |||
| EBITDA | (96.47 M) | |||
| Cash And Equivalents | 42.79 M | |||
| Cash Per Share | 0.49 X | |||
| Total Debt | 458 K | |||
| Debt To Equity | 0.1 % | |||
| Book Value Per Share | 1.32 X | |||
| Cash Flow From Operations | (74.98 M) | |||
| Earnings Per Share | (0.99) X | |||
| Total Asset | 146.01 M | |||
| Retained Earnings | (883.91 M) | |||
| Current Asset | 228.84 M | |||
| Current Liabilities | 20.18 M | |||
About Chimerix Performance
Evaluating Chimerix's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Chimerix has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Chimerix has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. Chimerix, Inc. was incorporated in 2000 and is headquartered in Durham, North Carolina. Chimerix operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 87 people.Things to note about Chimerix performance evaluation
Checking the ongoing alerts about Chimerix for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Chimerix help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Chimerix is not yet fully synchronised with the market data | |
| Chimerix has a very high chance of going through financial distress in the upcoming years | |
| The company reported the previous year's revenue of 212 K. Net Loss for the year was (88.39 M) with loss before overhead, payroll, taxes, and interest of (74.36 M). | |
| Chimerix currently holds about 42.79 M in cash with (74.98 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.49. | |
| Roughly 56.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from globenewswire.com: Heron Therapeutics Announces Preliminary, Unaudited Q4 and Full-Year 2025 Net Revenue ZYNRELEF Largest Contributor to Q4 Growth |
- Analyzing Chimerix's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Chimerix's stock is overvalued or undervalued compared to its peers.
- Examining Chimerix's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Chimerix's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Chimerix's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Chimerix's stock. These opinions can provide insight into Chimerix's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Other Consideration for investing in Chimerix Stock
If you are still planning to invest in Chimerix check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Chimerix's history and understand the potential risks before investing.
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |